Penatalaksanaan Karsinoma Sel Renal

Oleh :

dr.Nailla Fariq Alfiani

Penatalaksanaan karsinoma sel renal atau renal cell carcinoma (RCC) ditentukan berdasarkan stadium tumor, klasifikasi tumor, nodu, metastasis (TNM), kondisi umum pasien, serta stratifikasi risiko menggunakan International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Pilihan tata laksana mencakup pembedahan, terapi ablasi, maupun terapi sistemik.[1-3]

Terapi Lokal

Pada tumor lokal kecil (cT1a–cT1b, clinical T1a–T1b) yang medically inoperable atau tidak memungkinkan dilakukan pembedahan, terapi ablasi dapat dipertimbangkan. Pilihan termasuk radiofrequency ablation (RFA), cryoablation, atau stereotactic ablative radiotherapy (SABR), Pemilihan jenis terapi lokal didasarkan pada ukuran tumor, lokasi, kondisi ginjal residual, dan komorbiditas pasien.

Referensi

1. Bex A, et al. European Association of Urology (EAU) Guidelines on Renal Cell Carcinoma 2026. Arnhem: EAU Guidelines Office; 2026. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Renal-Cell-Carcinoma-2026.pdf
2. Powles T, et al; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024 Aug;35(8):692-706. doi: 10.1016/j.annonc.2024.05.537.
3. Quinn AE, Bell SD, Marrah AJ, Wakefield MR, Fang Y. The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2024 Dec 1;16(23):4034. doi: 10.3390/cancers16234034.
4. Ahn B, Kim JH, Lee SH, et al. Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 WHO Classification. Journal of Urologic Oncology. 2024. https://www.e-juo.org/journal/view.php?number=580
5. Pandey J, Syed W. Renal Cancer. StatPearls Publishing; 2026 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK558975/
6. Atkins MB, et al. Epidemiology, Pathology, and Pathogenesis of Renal Cell Carcinoma. UpToDate. 2026. https://www.uptodate.com/contents/epidemiology-pathology-and-pathogenesis-of-renal-cell-carcinoma#H1
7. Raghavendra AS, Kumar P, Sharma R, et al. Brief Note on Etiology and Pathophysiology Involved in Renal Cell Carcinoma. Journal of Clinical & Cellular Immunology. 2023. https://www.longdom.org/open-access/brief-note-on-etiology-and-pathophysiology-involved-in-renal-cell-carcinoma-104022.html
8. Zhang Y, Zhang S, Sun H, et al. The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma. Cell Death Discovery. 2025;11(1):186. https://www.nature.com/articles/s41420-025-02479-9
9. Sachdeva K. Renal Cell Carcinoma. Medscpe. 2025. https://emedicine.medscape.com/article/281340-overview#a4
10. National Cancer Institute. Genetics of Renal Cell Carcinoma (PDQ®)–Health Professional Version. Bethesda (MD): National Cancer Institute; 2025. https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics.
11. Luigi Cirillo, Samantha Innocenti, Francesca Becherucci. Global epidemiology of kidney cancer. Nephrology Dialysis Transplantation. Volume 39, Issue 6, June 2024, Pages 920–928, https://doi.org/10.1093/ndt/gfae036
12. Makino T, Kadomoto S, Izumi K, Mizokami A. Epidemiology and Prevention of Renal Cell Carcinoma. Cancers. 2022; 14(16):4059. https://doi.org/10.3390/cancers14164059
13. Mousavi SE, Najafi M, Aslani A, et al. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020. Sci Rep. 2024 May 17;14(1):11294. doi: 10.1038/s41598-024-61748-2.
14. Duha DA., Harahap EU., Santoso RB., et al. Kidney cancer profile in National Cancer Center (NCC) Dharmais Hospital Jakarta. Indones J Cancer. 2022;16(4). https://www.indonesianjournalofcancer.or.id/e-journal/index.php/ijoc/article/view/904/457
15. Anita KW., Kusuma ID., Rosyida RU. Clinicopathological Profile of Renal Cell Carcinoma at The Anatomical Pathology Laboratory, Saiful Anwar General Hospital From 2019 until 2023. GSC Biological and Pharmaceutical Sciences, 2025. 30(01), 192-196. https://doi.org/10.30574/gscbps.2025.30.1.0014
16. Bellin MF, Valente C, Bekdache O, et al. Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches. Cancers (Basel). 2024 May 18;16(10):1926. doi: 10.3390/cancers16101926.
17. Cardenas LM, Sigurdson S, Wallis CJD, Lalani AK, Swaminath A. Advances in the management of renal cell carcinoma. CMAJ. 2024 Feb 25;196(7):E235-E240. doi: 10.1503/cmaj.230356.
18. Hannan R, McLaughlin MF, Pop LM, et al. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. Eur Urol. 2023 Sep;84(3):275-286. doi: 10.1016/j.eururo.2023.02.016.
19. Li J, Luo P, Liu S, et al. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials. Mater Today Bio. 2024; 27:101149. doi:10.1016/j.mtbio.2024.101149.
20. Lyskjær I, Iisager L, Axelsen CT, et al. Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic. Clin Cancer Res. 2024 Feb 16;30(4):663-672. doi: 10.1158/1078-0432.CCR-23-1892.

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Masuk atau Daftar

Nomor Ponsel Sudah Terdaftar

Masuk dengan Email

Masuk dengan Email

Masuk dengan Facebook

Penatalaksanaan Karsinoma Sel Renal

Referensi

Masuk atau Daftar